deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT03472469

MAST Trial: Multi-modal Analgesic Strategies in Trauma (MAST)

Sponsor: National Center for Advancing Translational Sciences (NCATS)

Conditions Nonspecific Pain Post Traumatic Injury
Interventions Acetaminophen IV/PO Acetaminophen PO Celebrex Gabapentin Ketorolac Lidocaine Naproxen Opioids Pregabalin Regional anesthesia Tramadol
Updated 13 times since 2018 Last updated: Jun 15, 2021 Started: Apr 2, 2018 Primary completion: Jul 3, 2019 Completion: Jul 3, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03472469, this PHASE4 trial focuses on Nonspecific Pain Post Traumatic Injury and remains completed. Sponsored by National Center for Advancing Translational Sciences (NCATS), it has been updated 13 times since 2018, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~May 2019 · 11 months · monthly snapshot~May 2019 – ~Jul 2020 · 14 months · monthly snapshot~Jul 2020 – ~Aug 2020 · 31 days · monthly snapshot~Aug 2020 – ~Jan 2021 · 5 months · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~Oct 2022 · 13 months · monthly snapshot~Oct 2022 – ~Dec 2022 · 2 months · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

13 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE4

  4. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE4

  5. Oct 2022 — Dec 2022 [monthly]

    Completed PHASE4

▶ Show 8 earlier versions

  1. Sep 2021 — Oct 2022 [monthly]

    Completed PHASE4

  2. Jan 2021 — Sep 2021 [monthly]

    Completed PHASE4

  3. Aug 2020 — Jan 2021 [monthly]

    Completed PHASE4

  4. Jul 2020 — Aug 2020 [monthly]

    Completed PHASE4

    Status: Active Not Recruiting → Completed

  5. May 2019 — Jul 2020 [monthly]

    Active Not Recruiting PHASE4

    Status: Enrolling By Invitation → Active Not Recruiting

  6. Jun 2018 — May 2019 [monthly]

    Enrolling By Invitation PHASE4

  7. May 2018 — Jun 2018 [monthly]

    Enrolling By Invitation PHASE4

    Status: Not Yet Recruiting → Enrolling By Invitation

  8. Apr 2018 — May 2018 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Center for Advancing Translational Sciences (NCATS)
  • The University of Texas Health Science Center, Houston
Data source: The University of Texas Health Science Center, Houston

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations